The findings mean that for those using preexposure prophylaxis with gender-affirming hormone therapy or long-acting hormonal ...

Hormone therapy is indicated for vasomotor symptoms, not weight loss, suggesting the need to better understand why the ...

Trodelvy did not meet the primary endpoint of progression-free survival in the ASCENT-07 trial for HR-positive, HER2-negative ...

Indeed, risk factors for autoimmune diseases in postmenopausal women include dysbiosis, low vitamin D, and immune aging; ...

Even though nearly all women—approximately 85%—report experiencing menopause symptoms, science has offered very few solutions ...

In the trendy Brera district, two women in their 70s sell flowers that are never out of season. For more than 30 years, Laura ...

Midlife weight gain is a persistent challenge for many women, but emerging research suggests hormone therapy may enhance response to glucagon-like peptide-1 (GLP-1)–based treatments.

In preclinical studies, researchers at Sylvester Comprehensive Cancer Center, part of the University of Miami Miller School ...

Everyone said it would be trial and error, and I just went through a lot of error,’ the 50-year-old Hollywood veteran said ...

HR-positive/HER2-negative breast cancer grows with estrogen or progesterone, lacking high HER2 protein levels, making hormone ...

Menopause can bring a wave of physical and emotional changes—and for people with cancer, those changes can start earlier or ...

And, perimenopause can last for several years, as hormone levels wax and wane. While estrogen therapy, once controversial, has been shown effective and safe, according to The Menopause Society, ...